Medicare drug coverage faces an ominous spending outlook
AI Summary
Medicare's overhaul under the Inflation Reduction Act is leading to a significant rise in program spending, raising concerns about future coverage for seniors' outpatient prescription drugs. This increase could lead to difficult choices regarding Medicare's growing share of the national debt over the next decade. The act's aim to limit seniors' drug costs has shifted the financial burden to taxpayers, potentially impacting the program's sustainability and broader fiscal health.
Original Source
Read the full article at Axios →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.